Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
28.46
-0.46 (-1.59%)
At close: Feb 27, 2026, 4:00 PM EST
28.88
+0.42 (1.48%)
After-hours: Feb 27, 2026, 7:59 PM EST
Beam Therapeutics Employees
Beam Therapeutics had 511 employees as of December 31, 2025. The number of employees increased by 28 or 5.80% compared to the previous year.
Employees
511
Change (1Y)
28
Growth (1Y)
5.80%
Revenue / Employee
$273,470
Profits / Employee
-$156,540
Market Cap
2.83B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Apellis Pharmaceuticals | 739 |
| Arcus Biosciences | 627 |
| Travere Therapeutics | 385 |
| Wave Life Sciences | 288 |
| Dyne Therapeutics | 240 |
| Vera Therapeutics | 224 |
| Catalyst Pharmaceuticals | 181 |
| Liquidia | 170 |
BEAM News
- 1 day ago - Beam Therapeutics: Great Potential, But Patience Is Needed - Seeking Alpha
- 4 days ago - Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - What's Going On With Beam Therapeutics Stock? - Benzinga
- 4 days ago - Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU) - GlobeNewsWire
- 4 days ago - Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street - GlobeNewsWire
- 5 days ago - Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program - GlobeNewsWire
- 6 weeks ago - Beam Therapeutics Inc. (BEAM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Beam Therapeutics: Pivoting From Platform To Execution Stage - Seeking Alpha